Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-01 14:15:55 - browse：8757

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： 2 US Navy sailors arrested for allegedly spying for China

focus

WSS

MoonLake credibility takes another hit with mid

The new shift in health care is toward less care

UCSF medical school apologizes for unethical prisoner experiments

STAT Executive Editor Rick Berke on STAT's 8th birthday

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

leisure time

Wikipedia

explore

Jerome Adams on the need for new antivirals for Covid

TytoCare raises $49 million to build out AI

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A cyberattack has disrupted hospitals and health care in several states

Psychedelics group wrestles with new pharma identity

HPV cancer vaccine study demonstrates efficacy

Psychedelics group wrestles with new pharma identity

Diversify hospital leadership teams to protect BIPOC patient health

Medical leaders decry Supreme Court decision on affirmative action

Will General Catalyst be the first of many hospital takeovers?

leisure time

What Henrietta Lacks settlement says about racism in medicine

Diversify hospital leadership teams to protect BIPOC patient health

'Ancient DNA,' 23andMe reveal African American ancestries

Ambulance rides for just $100? Advisers want major billing fixes

FDA approves potent Eli Lilly obesity drug, Zepbound

What Mike Pence has said that could be used in a Donald Trump trial

entertainment

focus

explore

hotspot